For the Inventor, By the Inventor

Enter assignee name

Guangdong, China

Shenzhen Targetrx, Inc.

USPTO Granted Patents = 37

EPO Patents = 26

Forward Citations = 18

Loading Chart...

Loading Chart...

8 inventors (with patents filed for the assignee):

Yihan Wang (37 out of 38 patents)

Huanyin Li (14 out of 14 patents)

Jiuyang Zhao (9 out of 9 patents)

4. Yixin Ai (7 out of 7 patents)

5. Xingye Ren (6 out of 6 patents)

6. Qingfeng Xing (5 out of 5 patents)

7. Zhiqiang Liu (4 out of 18 patents)

8. Jian Jin (1 out of 1 patent)

9. Yixin Al (0 patent)

Core Competencies:

Protein Kinase

Inhibitors

Piperidines

Aminopyrimidine

Macrocyclic

Heterocyclic

Benzimidazole

Pyrazole

Aromatic Compounds

Nucleoside

Tyrosine Kinase

Antiviral

37 patents: Sort by Forward Citations

1. 12662484 - Substituted piperidines as bruton's tyrosine kinase inhibitors (2026-06-23),

2. 12365685 - Substituted fused aromatic ring derivative, composition and use thereof (2025-07-22),

3. 12312329 - Aminopyrimidine compound used for inhibiting activity of protein kinase (2025-05-27),

4. 12264151 - Substituted diamino heterocyclic carboxamide compound and a composition containing the compound and use thereof (2025-04-01),

5. 12129266 - Substituted pyrazolo[1,5-a]pyridine compound, composition containing the same and use thereof (2024-10-29),

6. 12116348 - Substituted benzimidazole compound and composition comprising same (2024-10-15),

7. 12077528 - Preparation method for deuterated macrocyclic compound (2024-09-03),

8. 12076320 - Diarylpyrazole compound, composition comprising same, and use thereof (2024-09-03),

9. 11840535 - Alkynyl(hetero)aromatic compound for inhibiting protein kinase activity (2023-12-12),

10. 11802113 - Substituted pyrazole compounds, compositions containing same, and use thereof (2023-10-31),

11. 11746110 - Alkynyl (hetero) aromatic ring compounds used for inhibiting protein kinase activity (2023-09-05),

12. 11718611 - Benzenesulfonylbenazamide compound for inhibiting BCL-2 protein and composition and use thereof (2023-08-08),

13. 11517561 - Macrocycle and composition comprising thereof (2022-12-06),

14. 11512074 - Substituted diamino heterocyclic carboxamide compound and a composition containing the compound and use thereof (2022-11-29),

15. 11485729 - Substituted pyridazinone compound (2022-11-01),

Company Overview

Shenzhen Targetrx, Inc. is a prominent player in the biotechnology sector, specializing in the development and manufacturing of innovative medical devices and diagnostic solutions. The company focuses on enhancing healthcare outcomes through advanced technologies, particularly in areas such as molecular diagnostics and therapeutic applications. Based in Guangdong, China, Targetrx is committed to leveraging cutting-edge research to address critical health challenges, contributing to the global advancement of medical science.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

37 Patents

#10 in Guangdong

#857 in China

#18,299 in the World

Guangdong, China

Shenzhen Targetrx, Inc.

Forward Citations = 18

8 inventors:

Yihan Wang (37 out of 38 patents)

Huanyin Li (14 out of 14 patents)

Jiuyang Zhao (9 out of 9 patents)

4. Yixin Ai (7 out of 7 patents)

5. Xingye Ren (6 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Shenzhen Targetrx, Inc.. Retrieved from https://idiyas.com/company/shenzhen-targetrx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…